Tenax Therapeutics, Inc.【TENX】 利益剰余金の推移

(単位:千ドル) 利益剰余金 前年比(%)
2Q25 -336,110 +10.3%
1Q25 -325,263 +8.0%
4Q24 -314,855 +5.9%
3Q24 -308,588 +5.0%
2Q24 -304,628 +4.3%
1Q24 -301,052 +3.5%
4Q23 -297,253 +2.7%
3Q23 -294,028 +2.5%
2Q23 -292,056 +2.8%
1Q23 -290,949 +3.5%
4Q22 -289,543 +4.0%
3Q22 -286,994 +4.3%
2Q22 -284,077 +4.6%
1Q22 -281,216 +4.2%
4Q21 -278,495 +13.2%
3Q21 -275,284 +13.2%
2Q21 -271,485 +12.7%
1Q21 -269,768 +13.0%
4Q20 -246,020 +4.2%
3Q20 -243,191 +4.2%
2Q20 -240,970 +4.2%
1Q20 -238,824 +4.1%
4Q19 -236,169 +3.7%
3Q19 -233,377 +7.0%
2Q19 -231,154 +6.7%
1Q19 -229,392 +6.9%
4Q18 -227,802 +6.7%
3Q18 -218,082 +2.8%
2Q18 -216,551 +2.7%
1Q18 -214,680 +3.2%
4Q17 -213,500 +4.3%
3Q17 -212,156 +21.2%
2Q17 -210,922 +23.5%
1Q17 -207,936 +25.2%
4Q16 -204,660 -
3Q16 -175,013 +20.1%
2Q16 -170,739 +19.6%
1Q16 -166,098 -
2Q16 -157,227 +10.1%
1Q16 -153,703 -
3Q15 -145,681 -
2Q15 -142,813 -
4Q14 -136,586 +16.7%
4Q13 -117,045 +8.7%
3Q13 -115,186 +9.7%
2Q13 -112,773 +15.4%
1Q13 -111,215 +17.3%
4Q12 -107,629 -
3Q12 -105,014 -
2Q12 -97,715 -
1Q12 -94,786 -